A PHASE 1 STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF MULTIPLE DOSES OF HM15211 IN OBESE SUBJECTS WITH NAFLD AND IN SUBJECTS WITH NASH

Administered By

Awarded By

Contributors

Start/End

  • October 23, 2018 - October 13, 2020